Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets

Front Oncol. 2022 Nov 10:12:1075329. doi: 10.3389/fonc.2022.1075329. eCollection 2022.

Authors

Adviti Naik¹, Joe Yeong^{2

3}, Julie Decock^{1

4}

Affiliations

¹ Translational Cancer and Immunity Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar.
² Institute of Molecular and Cell Biology (ASTAR), Singapore, Singapore.
³ Division of pathology, Singapore General Hospital, Singapore, Singapore.
⁴ College of Health and Life Sciences (CHLS), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar.

No abstract available

Keywords: cancer biology; cancer biomarker; cancer testis antigen; cancer therapy; immunotherapy.

Publication types

Editorial